Gene · 3363
Papers1,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Which halogen to choose? Comparing the effects of chlorine and fluorine as bioisosteric substituents in drug design. | Chem Sci | 2026 | 41561465 | PubTator, text mining | PubMed |
| Inflammatory cytokines are not associated with early age-related macular degeneration: a two-sample Mendelian randomisation study. | Eye (Lond) | 2026 | 41559451 | PubTator, text mining | PubMed |
| The Role of Danavorexton for Perioperative Opioid-Induced Respiratory Depression and Sedation: A Narrative Review. | Clin Pharmacol | 2026 | 41555862 | PubTator, text mining | PubMed |
| Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. | Cell Metab | 2026 | 41412121 | PubTator, text mining | PubMed |
| Network pharmacology, molecular docking and molecular dynamics simulation suggest CE-326597 as an antimalarial molecule. | In Silico Pharmacol | 2026 | 41393793 | PubTator, text mining | PubMed |
| G protein subtype preference dictates paroxetine-enhanced serotonin receptor response in non-malignant breast epithelial cells. | Biochem Pharmacol | 2026 | 41344514 | PubTator, text mining | PubMed |
| Serotonin receptor type 7 (5-HT7) promotes colorectal cancer progression by activating Wnt/β-catenin signaling via interacting with CK1ε. | Oncogene | 2026 | 41299067 | PubTator, text mining | PubMed |
| The therapeutic potential of scaffold containing substituted amine derivatives in the drug design of antidepressant compounds. | Eur J Med Chem | 2026 | 41270646 | PubTator, text mining | PubMed |
| Intelligent consensus-based QSAR modeling and virtual screening of dual inhibitors of 5HT1A/5HT7 serotonin receptors. | Comput Biol Chem | 2026 | 40819527 | PubTator, text mining | PubMed |
| Across preclinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions. | Front Drug Discov (Lausanne) | 2025 | 42239657 | PubTator, text mining | PubMed |
| A Prognostic Neuromodulation-Related Gene Signature Identifies Immunomodulation and Tumour-Associated Hallmarks in Glioblastoma. | Biomedicines | 2025 | 41301734 | PubTator, text mining | PubMed |
| Impact of pesticide diazinon on gastric cancer cell lines and the alteration of cholinergic and serotonergic pathway genes affecting cell proliferation. | Sci Rep | 2025 | 41254172 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis of HTR7: A potential biomarker for diagnosis, survival, and immunotherapy in pan-cancer. | PLoS One | 2025 | 41237175 | PubTator, text mining | PubMed |
| The molecular footprint of the serotoninergic system in human glioblastoma cells. | J Mol Histol | 2025 | 41219608 | PubTator, text mining | PubMed |
| Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation. | Ann Transl Med | 2025 | 41211118 | PubTator, text mining | PubMed |
| Novel Dual 5-HT7 Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities. | Pharmaceuticals (Basel) | 2025 | 41155600 | PubTator, text mining | PubMed |
| PCSK9 inhibitor failure in a statin-intolerant FH patient with a novel LDLR variant: a case report. | Front Cardiovasc Med | 2025 | 41059439 | PubTator, text mining | PubMed |
| Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders. | Front Immunol | 2025 | 40934003 | PubTator, text mining | PubMed |
| Supplementing HIV-ART with cannabinoids increases serotonin, BHB, and Ahr signaling while reducing secondary bile acids and acylcholines. | Sci Adv | 2025 | 40901952 | PubTator, text mining | PubMed |
| Organic Fusion of Molecular Simulation and Wet-Lab Validation: A Promising High-Throughput Strategy for Screening Bioactive Food Peptides. | Foods | 2025 | 40870802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3363/papers?page=2